Global pharmaceutical companies are accelerating efforts to expand their operations in the United States amid growing concerns over potential tariff impositions. With trade tensions escalating and the threat of increased tariffs on imported drugs looming, major drugmakers are strategizing to bolster their domestic manufacturing and supply chains. This shift underscores the industry’s urgent push to mitigate risks and safeguard market access in one of its most critical and lucrative markets, Reuters reports.
Global Pharmaceutical Giants Accelerate US Expansion Amid Rising Tariff Concerns
Pharmaceutical conglomerates from Europe and Asia are intensifying efforts to expand their manufacturing and distribution foothold within the United States as protectionist trade measures cast a…
—-
Author : Sophia Davis
Publish date : 2025-12-04 02:29:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8
